Hyperphenylalaninemia due to DNAJC12 deficiency: A Patient Guide

Hyperphenylalaninemia due to DNAJC12 deficiency is an ultra-rare genetic condition that changes how the body handles protein and how the brain communicates. At its core, the condition involves a “helper protein” called DNAJC12 that is either missing or not working correctly. This helper protein is vital because it stabilizes the enzymes responsible for breaking down phenylalanine (an amino acid found in protein) and creating the brain’s essential chemical messengers, dopamine and serotonin ^[1][2].

Because DNAJC12 deficiency affects several different systems, it often presents a double-sided challenge. On one side, phenylalanine can build up in the blood, which is why the condition is often first flagged on newborn screens and mistaken for PKU (Phenylketonuria). On the other side, the shortage of dopamine and serotonin can impact brain development and physical coordination. This dual nature means that while the condition shares features with more common metabolic disorders, it requires its own unique approach to management and care ^[3][4].

The symptoms of DNAJC12 deficiency exist on a broad spectrum, and no two individuals experience the condition in exactly the same way. Some people may remain asymptomatic or have very few symptoms, while others may face challenges with speech, learning, or social interaction. As children grow into adolescence and adulthood, the focus often shifts toward the motor system, where a lack of dopamine can lead to movement difficulties such as stiffness or tremors. Identifying these signs early is key to ensuring the brain gets the support it needs during critical years of growth ^[5][6].

Modern treatment strategies focus on addressing both the blood chemistry and the brain’s chemical needs based on individual symptoms. This typically involves an individualized approach: medication to help process phenylalanine, along with prescription medications that act as precursors to provide the brain with the materials it needs to produce dopamine and serotonin. When started early, these specialist-directed options—sometimes paired with dietary adjustments—may offer neurodevelopmental benefits, though long-term outcomes remain uncertain due to the rarity of the condition. While the diagnosis is rare and complex, a dedicated care team and consistent monitoring can help you navigate this spectrum ^[1][2].